keyword
https://read.qxmd.com/read/38702243/transient-hematotoxicity-after-emerald-horned-pitviper-ophryacus-smaragdinus-envenomation-a-case-report
#61
JOURNAL ARTICLE
Devin Shumway, Karen Pho, Nichole Andrews, Spencer Greene
BACKGROUND: A minority of snake envenomations in the United States involve non-native snakes. In this report, we describe what we believe is the first documented human envenoming from an emerald horned pitviper, Ophryacus smaragdinus. CASE REPORT: A previously healthy 36-year-old woman was bitten on her left index finger by a captive emerald horned pitviper she was medicating at work. Swelling to the entire hand was present on emergency department arrival. She had no systemic symptoms and her initial laboratory studies were unremarkable...
January 10, 2024: Journal of Emergency Medicine
https://read.qxmd.com/read/38702165/effect-of-nonpharmacological-methods-on-pruritus-in-patients-with-liver-disease-and-liver-cirrhosis-systematic-review
#62
JOURNAL ARTICLE
Yasemin Çayir, Meral Gün, Emine Kaplan Serin
BACKGROUND: Pruritus is a symptom that greatly affects the quality of life in patients with liver disease and liver cirrhosis. Since most pharmacological methods for itching have limited efficacy, there is a need to assess the effectiveness of nonpharmacological methods. PURPOSE: This systematic review aims to examine the effects of nonpharmacological methods on itching in individuals with liver disease and liver cirrhosis. METHODS: PRISMA-P (Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols) criteria were used as the basis for creating the systematic review protocol and writing the article...
May 3, 2024: Alternative Therapies in Health and Medicine
https://read.qxmd.com/read/38699580/tattoo-pruritus-successfully-treated-with-ruxolitinib-a-case-series
#63
Julianna Shin, Marie Leger
No abstract text is available yet for this article.
May 2024: JAAD Case Reports
https://read.qxmd.com/read/38698653/eye-movement-desensitization-protocol-for-urge-to-reduce-scratching-behaviour-in-patients-with-prurigo-nodularis-a-pilot-study
#64
JOURNAL ARTICLE
Mathijs R De Veer, Leonieke W Kranenburg, Tamar E C Nijsten, Jan J Busschbach, Rick Waalboer-Spuij
No abstract text is available yet for this article.
May 2, 2024: Acta Dermato-venereologica
https://read.qxmd.com/read/38698617/excimer-laser-therapy-for-pigmented-purpuric-dermatosis-a-case-study
#65
JOURNAL ARTICLE
Hannah Myers, Francesca M Ceci, Katherine Rupley, Michael Roberts
BACKGROUND Pigmented purpuric dermatosis (PPD) is a rare disease that is poorly understood but thought to result from inflammation of the capillaries causing extravasation of erythrocytes into the soft tissue. There are a variety of potential causes, including medications, such as acetaminophen and aspirin, abnormal humoral immunity, and excessive exercise. Although benign, PPD can be bothersome to patients due to associated pruritus, weeping, and poor cosmetic results. Treatment of this lesion is difficult, with no standardized regimen and a tendency for relapse once treatment is discontinued...
May 3, 2024: American Journal of Case Reports
https://read.qxmd.com/read/38697950/rapid-and-sustained-improvements-in-itch-and-quality-of-life-with-upadacitinib-plus-topical-corticosteroids-in-adults-and-adolescents-with-atopic-dermatitis-52-week-outcomes-from-the-phase-3-ad-up-study
#66
RANDOMIZED CONTROLLED TRIAL
Nina Magnolo, Michael C Cameron, Mona Shahriari, Bob Geng, Brian M Calimlim, Henrique Teixeira, Xiaofei Hu, Yang Yang, Yingyi Liu, Shiyu Zhang, Cristina Sancho Sanchez, Katherine Altman, Richard G Langley
Purpose: Atopic dermatitis (AD) adversely impacts quality of life (QoL). We evaluated the effect of upadacitinib, an oral selective Janus kinase inhibitor approved for moderate-to-severe AD, plus topical corticosteroids (+TCS) on patient-reported outcomes (PROs) over 52 weeks. Materials and methods: In the phase 3 AD Up study (NCT03568318), adults and adolescents with moderate-to-severe AD were randomized 1:1:1 to once-daily upadacitinib 15 mg, 30 mg, or placebo + TCS. Itch, skin pain/symptoms, sleep, QoL, daily activities, emotional state, mental health, and patient impressions of disease severity/improvement/treatment satisfaction were assessed...
December 2024: Journal of Dermatological Treatment
https://read.qxmd.com/read/38696233/a-systematic-review-of-procedural-modalities-in-the-treatment-of-notalgia-paresthetica
#67
JOURNAL ARTICLE
Mohammad Ali Nilforoushzadeh, Yekta Ghane, Nazila Heidari, Hanieh Azizi, Fatemeh Fathabadi, Niloufar Najar Nobari, Amirhossein Heidari
BACKGROUND: Notalgia paresthetica (NP) is a rare condition characterized by localized pain and pruritus of the upper back, associated with a distinct area of hyperpigmentation. Given the lack of standardized treatment and the uncertain efficacy of available options, applying procedural methods is of growing interest in treating NP. AIMS: We sought to comprehensively evaluate the role of procedural treatments for NP. METHODS: We systematically searched PubMed/Medline, Ovid Embase, and Web of Science until November 14th, 2023...
May 2024: Skin Research and Technology
https://read.qxmd.com/read/38696027/upadacitinib-rapidly-improves-patient-reported-outcomes-in-atopic-dermatitis-16-week-results-from-phase%C3%A2-3-clinical-trials-measure-up%C3%A2-1-and-2
#68
JOURNAL ARTICLE
Eric L Simpson, Vimal H Prajapati, Yael A Leshem, Raj Chovatiya, Marjolein S de Bruin-Weller, Sonja Ständer, Andrew E Pink, Brian M Calimlim, Wan-Ju Lee, Henrique Teixeira, Barry Ladizinski, Xiaofei Hu, Yang Yang, Yingyi Liu, Meng Liu, Ayman Grada, Andrew M Platt, Jonathan I Silverberg
INTRODUCTION: Atopic dermatitis (AD) is characterized by intense itch and other symptoms that negatively impact quality of life (QoL). This study evaluates the effect of upadacitinib (an oral selective Janus kinase inhibitor) monotherapy on patient-reported outcomes (PROs) among adults and adolescents with moderate-to-severe AD over 16 weeks. METHODS: This integrated analysis of the double-blind, placebo-controlled periods of phase 3 monotherapy clinical trials Measure Up 1 (NCT03569293) and Measure Up 2 (NCT03607422) assessed itch (Worst Pruritus Numerical Rating Scale [WP-NRS] and SCORing Atopic Dermatitis [SCORAD]), skin pain and symptom severity (AD Symptom Scale), symptom frequency (Patient-Oriented Eczema Measure), sleep (AD Impact Scale [ADerm-IS] and SCORAD), daily activities and emotional state (ADerm-IS), QoL (Dermatology Life Quality Index [DLQI] and Children's DLQI), mental health (Hospital Anxiety and Depression Scale), and patient impressions (Patient Global Impression of Severity, Patient Global Impression of Change, and Patient Global Impression of Treatment)...
May 2, 2024: Dermatology and Therapy
https://read.qxmd.com/read/38694505/efficacy-and-safety-of-different-immunotherapies-combined-with-chemotherapy-as-first-line-therapy-in-patients-with-small-cell-lung-cancer-a-network-meta-analysis
#69
JOURNAL ARTICLE
Siyao Gong, Qian Li, Xin Yu, Sha Yang
BACKGROUND: The efficacy and safety of different immunosuppressants combined with chemotherapy in treating patients with small-cell lung cancer (extensive-disease small-cell lung cancer, limited-disease small-cell lung cancer and relapsed small-cell lung cancer) are still unknown, and there are no reports directly comparing the efficacy and safety of other immunotherapies. OBJECTIVE: This study aimed to compare the efficacy and safety of first-line immunotherapy combined with chemotherapy in patients with small-cell lung cancer...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38693378/-not-available
#70
REVIEW
Cornelius Heyer
No abstract text is available yet for this article.
May 2024: MMW Fortschritte der Medizin
https://read.qxmd.com/read/38693146/the-relationship-between-fatigue-pruritus-and-thirst-distress-with-quality-of-life-among-patients-receiving-hemodialysis-a-mediator-model-to-test-concept-of-treatment-adherence
#71
JOURNAL ARTICLE
Hamid Sharif-Nia, João Marôco, Erika Sivarajan Froelicher, Saeed Barzegari, Niloofar Sadeghi, Reza Fatehi
Hemodialysis is a conservative treatment for end-stage renal disease. It has various complications which negatively affect quality of life (QOL). This study aimed to examine the relationship between fatigue, pruritus, and thirst distress (TD) with QOL of patients receiving hemodialysis, while also considering the mediating role of treatment adherence (TA). This cross-sectional study was carried out in 2023 on 411 patients receiving hemodialysis. Participants were consecutively recruited from several dialysis centers in Iran...
May 1, 2024: Scientific Reports
https://read.qxmd.com/read/38691294/efficacy-and-safety-of-neoadjuvant-subcutaneous-envafolimab-in-dmmr-msi-h-locally-advanced-colon-cancer
#72
JOURNAL ARTICLE
Yuan Li, Weili Zhang, Jie Du, Jinlong Hu, Ruixi Hu, Ziyang Zeng, E-Er-Man-Bie-Ke Jin-Si-Han, Shaopu Lian, Hao Wang, Yunfeng Li, Zhizhong Pan, Cheng Feng, Xuan Zhang, Zhenhai Lu
BACKGROUND: Neoadjuvant immunotherapy with programmed death-ligand 1 blockade for colon cancer, especially for mismatch repair-deficient (dMMR)/high microsatellite instability (MSI-H) colon cancer, has gained considerable attention recently. OBJECTIVE: This study aimed to assess the safety and efficacy of neoadjuvant subcutaneous envafolimab in patients with dMMR/MSI-H locally advanced colon cancer. METHODS: Patients with dMMR/MSI-H locally advanced colon cancer treated with envafolimab at Sun Yat-sen University Cancer Center and Yunnan Cancer Hospital from October 2021 to July 2023 were retrospectively reviewed and analyzed...
April 30, 2024: Targeted Oncology
https://read.qxmd.com/read/38690501/effects-of-intrathecal-morphine-administration-in-patients-undergoing-primary-total-hip-arthroplasty-under-spinal-anesthesia-with-quadratus-lumborum-block-for-postoperative-analgesia
#73
JOURNAL ARTICLE
Promil Kukreja, Kevin O'keefe, Jacelyn E Peabody Lever, Hanna Hussey, Paul D Piennette, Brooke Vining, Peter Nagi, Roland T Short, Scott Mabry, Hari Kalagara
Introduction Quadratus lumborum (QL) block has previously been shown to provide improved analgesia in patients undergoing primary total hip arthroplasty (THA) under spinal anesthesia when compared to spinal anesthesia alone. Additionally, recent studies have shown the addition of intrathecal morphine (ITM) to provide superior postoperative analgesia in patients undergoing various surgical interventions including total knee arthroplasty under spinal anesthesia with peripheral nerve blockade. At this time, however, there has not been a study evaluating the effects of intrathecal morphine in patients undergoing THA under spinal anesthesia with QL block...
March 2024: Curēus
https://read.qxmd.com/read/38690445/extremely-late-diagnosis-of-hereditary-angioedema-type-i-in-an-elderly-female
#74
Jonathan Estaris, Marina Ostroukhova
This case presents an instance of an extremely delayed diagnosis of hereditary angioedema (HAE) type I in an elderly female with no significant past medical history. The patient had a prolonged history of recurrent lip swelling and itchiness dating back to her teenage years, leading to multiple visits to the emergency room (ER). These recurrent episodes were characterized by random onset and accompanied by generalized pruritus and urticaria. During these ER visits, the patient would be inappropriately treated for presumed hypersensitivity reaction due to her confounding environmental allergies presenting with urticaria, complicating and significantly delaying her diagnosis...
March 2024: Curēus
https://read.qxmd.com/read/38690199/frequent-misdiagnosis-of-scabies-as-eczema-in-china-a-descriptive-study-of-23-cases
#75
JOURNAL ARTICLE
Xumei Wu, Feifei Yang, Ruina Zhang
OBJECTIVE: To outline the clinical manifestations observed in patients with scabies misdiagnosed as generalized eczema, analyse the factors contributing to these misdiagnoses and explore potential reasons for the resurgence of scabies. PATIENTS AND METHODS: A retrospective analysis was performed to investigate the patients with scabies misdiagnosed as generalized eczema. RESULTS: We included 23 patients, with twelve (52.17%) being male and eleven (47...
2024: International Journal of General Medicine
https://read.qxmd.com/read/38683088/-clinical-case-of-anaphylaxis-due-to-eye-drops
#76
JOURNAL ARTICLE
Iván Tinoco-Moran, Oscar Calderón-Liosa, Margarita Olivares-Gómez, Victor Farinango-Salazar, Iván Chérrez-Ojeda
BACKGROUND: Anaphylaxis is a severe systemic allergic reaction that can be life-threatening, timely diagnosis and treatment is required in these patients, one of the most frequent triggers is pharmacological. OBJECTIVE: To report the case of a patient who presented anaphylaxis due to eye drops. CASE REPORT: A 7-year-old male with a history of rhinitis and asthma with good control. It started with itchy eyes, ophthalmic drops were administered, composition: Polyethylene glycol 400, 0...
February 1, 2024: Revista Alergia Mexico: Organo Oficial de la Sociedad Mexicana de Alergia e Inmunología, A.C
https://read.qxmd.com/read/38683081/-anaphylaxis-due-to-legumes-case-report
#77
JOURNAL ARTICLE
Leidy Johana Alzate-Pérez, Natalia Aguirre-Morales, Libia Susana Diez-Zuluaga
BACKGROUND: Legumes belonging to the family Fabaceae of the order Fabales are a widely consumed source of protein. IgE-mediated hypersensitivity reactions to legumes have been described, the most studied allergens being peanuts and soybeans. In the Mediterranean region and India, lentils, chickpeas and peas have been considered important allergens and legumes have been reported to represent the fifth most common cause of food allergy in children under 5 years of age in Spain. In Latin America, there are few reports of allergy to legumes other than peanuts, and these are especially in the paediatric population...
February 1, 2024: Revista Alergia Mexico: Organo Oficial de la Sociedad Mexicana de Alergia e Inmunología, A.C
https://read.qxmd.com/read/38683068/-the-disease-under-chronic-urticaria-beyond-itching
#78
JOURNAL ARTICLE
Lucía Moreno-Lozano, Teresa De Aramburu-Mera, Carmen Bermúdez-Hormigo
BACKGROUND: Brief erythematous-papular skin rashes suggest the diagnosis of urticaria; However, it may be another type of dermatitis, and complementary examinations must be carried out to establish its diagnosis. CASE REPORT: 53-year-old female patient, diagnosed in 2016 with diffuse large B cell lymphoma, in complete remission. Since 2010, he has had episodes of erythematous-papular lesions lasting 24-36 hours. He received antihistamines, corticosteroids and omalizumab without clinical improvement...
February 1, 2024: Revista Alergia Mexico: Organo Oficial de la Sociedad Mexicana de Alergia e Inmunología, A.C
https://read.qxmd.com/read/38683062/-risk-factors-associated-to-adverse-drug-events-in-hospitalized-patients
#79
JOURNAL ARTICLE
María Del Rocío Hernández-Morales, Jorge Manuel Ramírez-Sánchez, Eleazar Mancilla-Hernández, Norma Lara-Dávalos, Samara Nazarala-Sanchez, Margarita Aguirre-Barbosa
OBJECTIVE: To determine prevalence, causes and risk factors of ADE in hospitalized patients. METHODS: Analytical, observational, case-control study of patients with ADE. For statistical analysis, the following were calculated: percentages, frequencies, averages; odds ratio, χ2 test and multiple binary logistic regression. Data analysis was carried out with the Statistical Package, for the Social Sciences 23 program. RESULTS: A 132 patients were registered: 66 cases (26 EM and 40 RAM) and 66 controls; with average age of 35 years (SD 17...
February 1, 2024: Revista Alergia Mexico: Organo Oficial de la Sociedad Mexicana de Alergia e Inmunología, A.C
https://read.qxmd.com/read/38682595/current-and-emerging-drugs-for-the-treatment-of-pruritus-an-update-of-the-literature
#80
REVIEW
Rami H Mahmoud, Sarah G Brooks, Gil Yosipovitch
INTRODUCTION: Pruritus, particularly in its chronic form, often imposes significant suffering and reductions in patients' quality of life. The pathophysiology of itch is varied depending on disease context, creating opportunities for unique drug development and multimodal therapy. AREAS COVERED: The purpose of this article is to provide an update of the literature regarding current and emerging therapeutics in itch. We review the multitudes of drug targets available and corresponding drugs that have shown efficacy in clinical trials, with a particular emphasis on phase 2 and 3 trials and beyond...
April 29, 2024: Expert Opinion on Pharmacotherapy
keyword
keyword
32335
4
5
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.